Commentary

Video

EyeCon 2024: Peter McDonnell, MD, and Laura Periman, MD, on the importance of integrating new knowledge into practice

Peter J. McDonnell, MD, and Laura M. Periman, MD, discuss recent innovations in ophthalmology, emphasizing ocular surface disease and the growing complexity of care at EyeCon 2024, held September 27 and 28, in Fort Lauderdale, Florida.

Peter J. McDonnell, MD, chief medical editor of Ophthalmology Times and co-director of EyeCon 2024, and Laura M. Periman, MD, founder of the Periman Eye Institute in Seattle, discuss recent innovations in ophthalmology, emphasizing ocular surface disease (OSD) and the growing complexity of care. Their conversation highlights advancements in ocular surface treatments, intraocular lenses, and management strategies for conditions like thyroid eye disease and geographic atrophy.

Periman shares insights into her specialty focus on OSD. She describes the evolution of her practice model and stresses the importance of time, patient-centered care, and technological integration in managing chronic eye conditions. This approach aims to address the gap in standard practice, where complex conditions often receive inadequate attention.

The conversation underscores the need for cross-specialty communication and continuous education. Ophthalmologists, regardless of their subspecialty, can benefit from a comprehensive understanding of OSD, as common surgeries like cataract and refractive procedures can exacerbate these conditions if not properly managed. Retina specialists are also urged to consider OSD management to enhance overall patient care.

The presenters highlight EyeCon’s role as a platform that bridges knowledge gaps across ophthalmology subspecialties. With the rising prevalence of myopia, age-related macular degeneration, and increasing patient demand, new care models and approaches are essential. McDonnell and Periman encourage attendees to integrate learnings into their practice, enhancing patient outcomes through shared expertise and a multidisciplinary approach to eye care.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.